Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Sernova Biotherapeutics Inc. (SEOVF) had Return on Equity of 16.67% for the most recently reported fiscal quarter, ending 2025-07-31.
| Income Statement Financials | |
-- |
|
$-2.96M |
|
-- |
|
-- |
|
$2.55M |
|
$-2.55M |
|
$-0.40M |
|
$-2.95M |
|
$-2.95M |
|
$-2.96M |
|
$-2.96M |
|
$-2.96M |
|
$-2.96M |
|
$-2.55M |
|
$-2.41M |
|
328.49M |
|
328.49M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.36M |
|
$0.07M |
|
$0.30M |
|
$0.66M |
|
$17.73M |
|
$0.71M |
|
$0.71M |
|
$18.44M |
|
$-17.78M |
|
$-17.78M |
|
$-17.78M |
|
328.49M |
|
| Cash Flow Statement Financials | |
$-7.81M |
|
$0.00M |
|
$3.50M |
|
$4.38M |
|
$0.06M |
|
$-4.31M |
|
$1.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
-0.04 |
|
-0.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.81M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
16.67% |
16.67% |
|
-447.31% |
|
17.37% |
|
$-0.05 |
|
$-0.02 |
|
$-0.02 |
|